Most recent technology transfer projects

Funding authority Programme Title Period
SPRIN-D Ein Quantensprung für neue antivirale Wirkstoffe MucBoost (D. Lauster, B. Kaufer, J. Trimpert/FU Berlin, Chr. Hackenberger/FMP, Chr. Sieben/HZI, P. Boisguerin/Inserm, and M. Hittinger/PharmBioTec) 11.2021 - 10.2022
Leibniz Association Leibniz-Transfer Selective depletion of plasma cells secreting pathogenic autoantibodies in chronic autoimmune diseases - a potentially curative therapeutic approach (F. Hiepe/Charité & DRFZ, A. Meisel/Charité, Chr. Hackenberger/FMP) 01.2021 - 12.2023
Crowdfunding Development of an enzyme replacement therapy for the treatment of transglutaminase-1-deficient autosomal recessive congenital ichthyosis (M. Dathe/FMP and H. Traupe/WWU) Ongoing
Leibniz Association Leibniz-Transfer Cystein‐selective bioconjugation for next generation antibody drug conjugates (Chr. Hackenberger/FMP) 03.2018 - 12.2022
Federal Ministry of Education and Research (BMBF) Targetvalidierung für die pharmazeutische Wirkstoffentwicklung Evaluating Ena/VASP as a novel relevant drug target for treatment of cancer metastasis (R. Kühne/FMP and H.-G. Schmalz/University of Cologne) 01.2018 - 04.2020
Bavarian Ministry of Economic Affairs and Media, Energy and Technology m4 Award Development of a Tubulis Technologies proprietary ADC for Acute Myeloid Leukemia treatment (Jonas Helma-Smets, Dominik Schumacher, Heinrich Leonhardt/LMU and Christian Hackenberger/FMP) 01.2018 - 12.2019
Federal Ministry for Economic Affairs and Energy (BMWi) EXIST Forschungstransfer I Tubulis Technologies, a pre-start-up project affiliated with the Ludwig Maximilians University Munich (LMU, Jonas Helma-Smets, Dominik Schumacher, Heinrich Leonhardt) and the FMP (Christian Hackenberger) 04.2017 - 09.2019